Core Laboratories
CLB
209 hedge funds and large institutions have $880M invested in Core Laboratories in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 58 increasing their positions, 73 reducing their positions, and 17 closing their positions.
124% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 17
53% more call options, than puts
Call options by funds: $279K | Put options by funds: $182K
9% more funds holding
Funds holding: 191 → 209 (+18)
0.59% less ownership
Funds ownership: 108.81% → 108.22% (-0.59%)
7% less capital invested
Capital invested by funds: $946M → $880M (-$66.3M)
21% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 73
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$6.75M |
| 2 |
BlackRock
New York
|
+$2.66M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$2.18M |
| 4 |
Goldman Sachs
New York
|
+$1.67M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$7.96M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.27M |
| 3 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$2.89M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.41M |
| 5 |
Morgan Stanley
New York
|
-$2.19M |
CLB Hedge Fund Activity: Q4 2024 in Review
209 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q4 2024, worth a combined $880M — down 7% from $946M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new CLB positions and 17 closed out — a net gain of 21 holders — while 58 added to existing stakes and 73 trimmed.
The largest buyer was UBS Group, adding an estimated $6.75M. The largest seller was Ariel Investments, cutting an estimated $7.96M.
- 209 institutional investors held Core Laboratories (CLB) as of Q4 2024, up from 191 in Q3 2024.
- Funds reported $880M of Core Laboratories stock for Q4 2024, down 7% quarter-over-quarter.
- 38 funds opened new Core Laboratories positions in Q4 2024 and 17 closed out, a net change of +21 holders.
- The largest Core Laboratories buyer in Q4 2024 was UBS Group, an estimated $6.75M added.
- The largest Core Laboratories seller in Q4 2024 was Ariel Investments, an estimated $7.96M sold.
Based on aggregated 13F filings for Q4 2024.